Aida Ajaz
About Aida Ajaz
Aida Ajaz is a Sr. Manager of Drug Substance Technical Operations at Bristol Myers Squibb with extensive experience in synthetic organic chemistry and pharmaceutical manufacturing.
Company
Aida Ajaz is currently employed at Bristol Myers Squibb as a Sr. Manager in Drug Substance Technical Operations. Bristol Myers Squibb is a renowned global biopharmaceutical company known for its innovative approach in treating serious diseases.
Title
Aida Ajaz holds the title of Sr. Manager, Drug Substance Technical Operations at Bristol Myers Squibb. Her role involves overseeing technical operations related to drug substance development and manufacturing.
Education and Expertise
Aida Ajaz has an educational background in Chemistry, having earned both a Bachelor of Science (BS) and a Master of Science (MS) from the University of New Hampshire. Her expertise includes multistep organic synthesis and utilizing modern techniques for production at both bench and kilo-lab scales.
Career Background
Aida Ajaz has a comprehensive career history in the pharmaceutical industry. She previously worked at Karuna Therapeutics as both Sr. Manager, Drug Substance Technical Operations and Manager, Drug Substance Manufacturing and Operations. Her past roles also include Scientist, Chemical Development at Concert Pharmaceuticals, Inc., Principal Associate Scientist and Senior Associate Scientist at Cyclerion, and Staff Chemist at Johnson Matthey. She started her career as a Process Chemist at PCI Synthesis and has research experience from the University of New Hampshire.
Industry Experience
Aida Ajaz has held multiple roles that illustrate her progression in the pharmaceutical sector, especially in drug substance technical operations and manufacturing. Her positions have spanned across major industry players, adding depth to her experience. Notable positions include Sr. Manager at Bristol Myers Squibb and Karuna Therapeutics, and Scientist roles at Concert Pharmaceuticals and Cyclerion. She has a strong background in synthetic organic chemistry, particularly in the pharmaceutical, fine chemical, and material science industries.